Prescient Therapeutics Limited PTX.AX
PTX.AX
Prescient Therapeutics Limited CYP.AX
Cynata Therapeutics Limited AGN.AX
Argenica Therapeutics Limited NSB.AX
NeuroScientific Biopharmaceuticals Limited EYE.AX
Nova Eye Medical Limited NXS.AX
Next Science Limited NOX.AX
Noxopharm Limited IIQ.AX
INOVIQ Ltd VIT.AX
Vitura Health Limited IMC.AX
Immuron Limited
Prescient Therapeutics Limited CYP.AX
Cynata Therapeutics Limited AGN.AX
Argenica Therapeutics Limited NSB.AX
NeuroScientific Biopharmaceuticals Limited EYE.AX
Nova Eye Medical Limited NXS.AX
Next Science Limited NOX.AX
Noxopharm Limited IIQ.AX
INOVIQ Ltd VIT.AX
Vitura Health Limited IMC.AX
Immuron Limited
Performance
| Periode | PTX.AX | CYP.AX | AGN.AX | NSB.AX | EYE.AX | NXS.AX | NOX.AX | IIQ.AX | VIT.AX | IMC.AX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -6.67 % | 25.64 % | -58.09 % | 226.09 % | 47.62 % | 51.52 % | 9.41 % | -9.09 % | 0.00 % | 25.00 % |
| YTD | -17.65 % | 2.08 % | -55.12 % | 354.55 % | -11.43 % | 30.43 % | 2.20 % | -33.96 % | -14.63 % | 2.56 % |
| 1Y | -4.55 % | 6.52 % | -63.46 % | 294.74 % | -16.22 % | -23.08 % | -19.13 % | -28.57 % | -39.13 % | 3.90 % |
| 3Y | -76.67 % | -26.87 % | -37.36 % | 64.84 % | -37.58 % | -80.65 % | -49.73 % | -39.66 % | -92.43 % | -8.05 % |
| 5Y | -34.38 % | -70.39 % | 9.62 % | -53.85 % | -50.26 % | -88.00 % | -79.56 % | -98.44 % | -19.54 % | -69.81 % |
| 10Y | -26.90 % | -48.81 % | 9.62 % | -33.33 % | -68.16 % | -88.89 % | -43.08 % | -59.92 % | -79.41 % | -85.59 % |
| From the beginning | -99.88 % | -90.54 % | 9.62 % | -33.33 % | -98.47 % | -88.89 % | -43.08 % | -99.85 % | -79.41 % | -98.85 % |